维普中文期刊产品整合服务
20篇 您的检索式:作者名="Han NN"
    题名 作者 年代 出处 被引量
1Portal vein thrombosis and arterioportal shunts:Effects on tumor response after chemoembolization of hepatocellular carcinoma显示文摘AIM: To evaluate the effect of portal vein thrombosis and arterioportal shunts on local tumor response in advanced cases of unresectable hepatocellular carcinoma treated by transarterial chemoembolization. METHODS: A retrospective study included 39 patients (mean age: 66.4 years, range: 45-79 years, SD: 7) with unresectable hepatocellular carcinoma (HCC) who were treated with repetitive transarterial chemoembolization (TACE) in the period between March 2006 and October 2009. The effect of portal vein thrombosis (PVT) (in 19 out of 39 patients), the presence of arterioportal shunt (APS) (in 7 out of 39), the underlying liver pathology,Child-Pugh score, initial tumor volume, number of tumors and tumor margin definition on imaging were correlated with the local tumor response after TACE. The initial and end therapy local tumor responses were evaluated according to the response evaluation criteria in solid tumors (RECIST) and magnetic resonance imaging volumetric measurements. RESULTS: The treatment protocols were well tolerated by all patients with no major complications. Local tumor response for all patients according to RECIST criteria were partial response in one patient (2.6%), stable disease in 34 patients (87.1%), and progressive disease in 4 patients (10.2%). The MR volumetric measurements showed that the PVT, APS, underlying liver pathology and tumor margin definition were statistically significant prognostic factors for the local tumor response (P = 0.018, P = 0.008, P = 0.034 and P = 0.001, respectively). The overall 6-, 12- and 18-mo survival rates from the initial TACE were 79.5%, 37.5% and 21%, respectively. CONCLUSION: TACE may be exploited safely for palliative tumor control in patients with advanced unresectable HCC; however, tumor response is significantly affected by the presence or absence of PVT and APS.Thomas J Vogl Nour-Eldin Nour-Eldin Sally Emad-Eldin Nagy NN Naguib Joerg Trojan Hans Ackermann Omar Abdelaziz 2011World Journal of Gastroenterology2011,17,10:20
2Immunohistochemistry reliablydetects ALK rearrangements in patients with advanced non-small-cell lung cancer显示文摘Han XH Zhang NN Ma L 2013Virchows Arch2013,463,4:1
3Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study显示文摘Gunnar J?rnerot Erik Hertervig Ingalill Friis-Liby Lars Blomquist Per Karlén Christer Gr?nn? Mogens Vilien Magnus Str?m ?ke Danielsson Hans Verbaan Per M. Hellstr?m Anders Magnuson Bengt Curman 2005Gastroenterology2005,,7:1
4Antimyein A18 produced by an endophytic Streptomyces albidoflavus isolated from a mangrove plant显示文摘Yan LL Han NN Zhang YQ 2010The Journal of Antibiotics2010,63,5:1
5Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study显示文摘Gunnar J?rnerot Erik Hertervig Ingalill Friis-Liby Lars Blomquist Per Karlén Christer Gr?nn? Mogens Vilien Magnus Str?m ?ke Danielsson Hans Verbaan Per M. Hellstr?m Anders Magnuson Bengt Curman 2005Gastroenterology2005,,7:1
6Pretreatment with low dose etomidate prevents etomidate-induced rat adrenal insufficiency by regulating oxi- dative stress-related MAPKs and apoptosis 显示文摘Liu S Zhang XP Han NN 2015Environ Toxieol Phar- macol2015,39,3:1
7Pretreatment with low dose etomi- date prevents etomidate-induced rat adrenal insufficiency by regulat- ing oxidative stress-related MAPKs and apoptosis 显示文摘Liu S Zhang XP Han NN 2015Environmental toxicology and pharmacology2015,39,3:1
8Chinese herbal medicine Guizhi Fuling Formula for treatment of uterine fibroids:a systematic review of randomised clinical trials显示文摘Chen NN Han M Yang H 2014BMC Complement Altern Med2014,14,:1
9Asymmetric dimethylarginine ( ADMA) :a potential link between endothelial dysfunetion and cardiovascular diseases in insulin resistance syndrome? 显示文摘Han NN Chan JCN 2002Diabetologia2002,45,9:1
10Rgsl and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility with in lymph node follicles 显示文摘Han SB Moratz C Huang NN 2005Immunity2005,22,3:1
11Immunohistochemistry reliably detects ALK rearrangements in patients with advanced non-small- cell lung cancer显示文摘Han XH Zhang NN Ma L 2013Virchows Arch2013,463,4:1
12Immunohistochemistry reliably detects ALK rearrangements in patients with advanced non-small- cell lung cancer显示文摘Han XH Zhang NN Ma L 2013Virchows Arch2013,463,4:1
13Immunohistochemistry reliably detects ALK rearrangements in patients with advanced non-smallcell lung cancer显示文摘Han XH Zhang NN Ma L 2013Virchows Arch2013,463,4:1
14Application of an autoregressive inte- grated moving average model for predicting the incidence of hemor- rhagic Fever with renal syndrome显示文摘Li Q Guo NN Han ZY 2012Am J Trop Med Hyg2012,87,2:1
15Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle 显示文摘Han XX Chabowski A Tandon NN 2007Am J Physiol En- docrinol Metab2007,293,2:1
16Study of paraoxonase-1 function on tissue damage of dichlorvos显示文摘Wang NN Yuan L Han ZK 2010Toxicol Lett2010,196,2:1
17Antimycin A18 produced by an endophytic Streptomyces albidoflavus isolated from a mangrove plant显示文摘Yan LL Han NN Zhang YQ 2010J Antibiot2010,63,5:1
18RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization 显示文摘Han JI Huang NN Kim DU 2006J Leukoc Biol2006,79,6:1
19Application of an autoregressive integrated movin$ average model for predicting the incidence of hemorrhagic fever with renal syndrome 显示文摘LI Q GUO NN HAN ZY 2012American Journal of Tropical MedicineandHygiene2012,87,2:1
20Serological response to chemopro- phylaxis in extended contacts in leprosya randomized con- trolled trial 显示文摘Oo KN Yin NN Han TT 2008Nihon Hansenbyo Gasshi2008,77,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费